Completed NA INTERVENTIONAL 2-arm NCT00947505

Treatment of Androgenetic Alopecia in Males

A Randomized, Double-Blind, Control Device Clinical Trial to Evaluate the Safety and Efficacy of the HairMax LaserComb 2009, 7 Beam Model: For the Treatment of Androgenetic Alopecia in Males

Sponsor: Lexington International, LLC

Conditions Androgenetic Alopecia Hair Loss Male Pattern Baldness

Interventions HairMax LaserComb HairMax LaserComb 2009, 7 Beam

Updated 8 times since 2017 Last updated: Jun 21, 2012 Started: Aug 31, 2009 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Androgenetic Alopecia and Hair Loss and is currently completed. Lexington International, LLC leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lexington International, LLC

Data source: Lexington International, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Austin, United States
• Palm Beach, United States